Research Article

Evaluation of the Anti-Inflammatory Impact of Vitamin D on Polycystic Ovary Syndrome and Endometriosis

Volume: 12 Number: 2 August 22, 2022
EN

Evaluation of the Anti-Inflammatory Impact of Vitamin D on Polycystic Ovary Syndrome and Endometriosis

Abstract

Objective: Although numerous studies demonstrate the link between vitamin D and its anti-inflammatory effects, the correlations could not be fully explained. Platelet-lymphocyte ratio (PLR) and neutrophil-lymphocyte ratio (NLR) are investigated as biomarkers for diagnosis and follow-up in various obstetrics and gynecological studies. We aimed to evaluate the correlation between the anti-inflammatory effect of vitamin D and inflammatory parameters NLR and PLR in women with polycystic ovary syndrome (PCOS) and endometriosis.

Materials and Methods: Serum 25-hydroxy vitamin D (25(OH)D) levels, complete blood count (CBC) parameters, NLR, PLR, Vitamin B12, and thyroid stimulating hormone (TSH) levels of 140 patients who applied to the Department of Obstetrics and Gynecology between 2010-2019 were evaluated. In our study, the levels of 25(OH)D, TSH, vitamin B12 and CBC measurements were analyzed simultaneously. SPSS 22.0 Windows version software was utilized in the data analysis, and p<0.05 was accepted as statistical significance level.

Results: There were significant differences in NLR (p=0.026) and lymphocytes count between PCOS and endometriosis groups (p=0.010). When we examined PCOS and endometriosis patients as a patient group; according to 25(OH)D vitamin levels, we found that NLR was significantly higher in the group with 25(OH)D vitamin levels below 20 ng/ml (p=0.017), vit B12 levels were significantly lower (p=0.034). Bivariate correlation analysis showed that vitamin D was negatively correlated with NLR (r=-0.196, p=0.050) in the patients with PCOS but not with endometriosis.

Conclusion: This retrospective study assessed the association between vitamin D levels and the new inflammation biomarkers in patients with PCOS and endometriosis. The CBC and neutrophil/lymphocyte ratios are accessible and easily measurable biomarkers, therefore, evaluating the anti-inflammatory effect of vitamin D together with NLR is valuable for both PCOS and endometriosis.

Keywords

References

  1. 1. Holick, M.F., High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc, 2006. 81(3): p. 353-73.
  2. 2. Aygun, H., Vitamin D can prevent COVID-19 infection-induced multiple organ damage. Naunyn Schmiedebergs Arch Pharmacol, 2020. 393(7): p. 1157-1160.
  3. 3. Grudet, C., J. Malm, A. Westrin, and L. Brundin, Suicidal patients are deficient in vitamin D, associated with a pro-inflammatory status in the blood. Psychoneuroendocrinology, 2014. 50: p. 210-9

Details

Primary Language

English

Subjects

Clinical Sciences

Journal Section

Research Article

Publication Date

August 22, 2022

Submission Date

April 30, 2022

Acceptance Date

June 23, 2022

Published in Issue

Year 2022 Volume: 12 Number: 2

APA
İşbilen, E., & Kömürcü Karuserci, Ö. (2022). Evaluation of the Anti-Inflammatory Impact of Vitamin D on Polycystic Ovary Syndrome and Endometriosis. Experimed, 12(2), 80-84. https://doi.org/10.26650/experimed.1111483
AMA
1.İşbilen E, Kömürcü Karuserci Ö. Evaluation of the Anti-Inflammatory Impact of Vitamin D on Polycystic Ovary Syndrome and Endometriosis. Experimed. 2022;12(2):80-84. doi:10.26650/experimed.1111483
Chicago
İşbilen, Elif, and Özge Kömürcü Karuserci. 2022. “Evaluation of the Anti-Inflammatory Impact of Vitamin D on Polycystic Ovary Syndrome and Endometriosis”. Experimed 12 (2): 80-84. https://doi.org/10.26650/experimed.1111483.
EndNote
İşbilen E, Kömürcü Karuserci Ö (August 1, 2022) Evaluation of the Anti-Inflammatory Impact of Vitamin D on Polycystic Ovary Syndrome and Endometriosis. Experimed 12 2 80–84.
IEEE
[1]E. İşbilen and Ö. Kömürcü Karuserci, “Evaluation of the Anti-Inflammatory Impact of Vitamin D on Polycystic Ovary Syndrome and Endometriosis”, Experimed, vol. 12, no. 2, pp. 80–84, Aug. 2022, doi: 10.26650/experimed.1111483.
ISNAD
İşbilen, Elif - Kömürcü Karuserci, Özge. “Evaluation of the Anti-Inflammatory Impact of Vitamin D on Polycystic Ovary Syndrome and Endometriosis”. Experimed 12/2 (August 1, 2022): 80-84. https://doi.org/10.26650/experimed.1111483.
JAMA
1.İşbilen E, Kömürcü Karuserci Ö. Evaluation of the Anti-Inflammatory Impact of Vitamin D on Polycystic Ovary Syndrome and Endometriosis. Experimed. 2022;12:80–84.
MLA
İşbilen, Elif, and Özge Kömürcü Karuserci. “Evaluation of the Anti-Inflammatory Impact of Vitamin D on Polycystic Ovary Syndrome and Endometriosis”. Experimed, vol. 12, no. 2, Aug. 2022, pp. 80-84, doi:10.26650/experimed.1111483.
Vancouver
1.Elif İşbilen, Özge Kömürcü Karuserci. Evaluation of the Anti-Inflammatory Impact of Vitamin D on Polycystic Ovary Syndrome and Endometriosis. Experimed. 2022 Aug. 1;12(2):80-4. doi:10.26650/experimed.1111483